Ouabain (1x10-7-3x10-i M) elicited concentration-dependent vasoconstriction in human placental arteries and veins. These responses, but not those produced by 10`M 5-hydroxytryptamine, were increased after the removal of vascular endothelium. In placental arteries, the respective blockade of cyclooxygenase or lipoxygenase with indomethacin or 5,8,11,15-eicosatetraynoic acid as well as the inactivation of nitric oxide with phenidone or oxyhemoglobin and the inhibition of nitric oxide synthesis with NG-monomethyl L-arginine (all at 10-M) did not mimic the effects of endothelial denudation on ouabain-evoked contractions. Bioassay experiments suggested that the above-mentioned endothelial effects are mediated by diffusible factors. 86Rb+ uptake, a method to measure sodium pump activity, was significantly reduced by the removal of endothelium. These results suggest the existence of an inhibitory modulation by the endothelium of the contractions induced by ouabain, likely mediated by a diffusible factor(s) released from these cells. The nature of this substance is unknown but is not related to prostaglandins or leukotrienes, and neither is it a nitric oxide-related compound. Its mechanism of action could be stimulating the activity of vascular sodium pump and/or antagonizing its inhibition by ouabain. (Circulation Research 1992;71:943-950) 
T he vascular sodium pump inhibition by cardiac glycosides or potassium-free solution evokes vasoconstriction in several beds from different animal species, including humans.1-7 These responses can be produced by a direct effect on smooth muscle cells (myogenic component) or by the release of norepinephrine from perivascular sympathetic nerve endings (neurogenic component); the predominant component depends on the vessel and the animal studied. In human vessels, the myogenic mechanism appears to mediate contraction by cardiac glycosides.4 In addition, the human umbilical and placental vasculature, which lacks autonomic innervation,10"11 exhibits important contractile responses to digitalis. 12"13 On the other hand, ouabain or potassium-free solution inhibits endothelium-dependent relaxations.'4"15 This effect can be produced by blocking the release of endothelium-derived relaxing factor (EDRF, believed to be nitric oxide [NO]) from endothelium1617 or by inhibiting the action of an "endothelium-dependent hyperpolarizing factor" (EDHF) on the smooth muscle cells. 16"8"9 In spite of these results, the influence of endothelium on the vascular responses to cardiac glycosides is scarcely known. Therefore, the aim of this work was to determine the possible modulation by the endo-thelium of the contractions induced by ouabain in human placental arteries and veins as well as the mechanisms involved. These vessels were selected for two reasons: 1) human chorionic vasculature is easily available and has an important role in the fetoplacental circulation,20 and 2) it lacks autonomic innervation, allowing for the specific analysis of the endothelial influence on the myogenic component of ouabain.
Materials and Methods

Collection of Vascular Preparations
The human placental vessels (2-4 mm o.d.) used in the present study were arteries and veins obtained from the chorionic plate. The placentas were obtained from full-term normal vaginal deliveries from healthy parturients 20-30 years old with neither relevant diseases nor drug treatment during pregnancy. Immediately after delivery, the vessels were carefully isolated and immersed in a beaker containing Krebs-Henseleit solution (KHS) at 4°C and carried to the laboratory. Then, they were divided into cylindrical segments 5 mm in length and cleaned of blood traces and adherent tissues.
Drug Effects on Vascular Tone
For isometric tension recording, each vascular cylinder was set up in an organ bath according to the method described by Marnn et al. 7 The organ chamber contained 5 ml KHS at 37°C continuously bubbled with a 95% 02-5% CO2 mixture, which gave a pH of 7.4. Two horizontally arranged stainless-steel pins (250-,um diameter) were passed through the lumen of the vascular cylinder. One pin was fixed to the organ bath wall; the other one was connected vertically to a strain gauge for isometric tension recording. The isometric contraction was recorded through a force-displacement transducer (model FTO3C, Grass Instrument Co., Quincy, Mass.) connected to a Grass model 7D polygraph. The segments were submitted to a tension of 1.5 g (optimal resting tension), which was readjusted every 15 minutes during a 120-minute equilibration period before administration of the drugs.
At the beginning of the experiment, the vessels were exposed to 75 mM K' to check their functional integrity. After a washout period, a concentration-response curve to ouabain was determined in a cumulative manner, adding the glycoside at intervals of approximately 30 minutes, that generally allowed the response of each concentration to become stable. Some segments were previously deendothelialized as described below. In other experiments, indomethacin, phenidone, oxyhemoglobin (OxHb), NG-monomethyl L-arginine (L-NMMA), 5,8,11,15-eicosatetraynoic acid (ETYA) (all of them at 10-5 M), or phentolamine (10`M) was added to the bath 15 minutes before ouabain. Control and experimental curves were done simultaneously in different segments from the same placenta because of the long-lasting effects of the glycoside and its difficult washout. In another set of experiments with the same protocol, segments of placental arteries and veins with or without endothelium were exposed to a single concentration of 10`6 M 5-hydroxytryptamine (5-UT) or contracted with 10`6 M prostaglandin Fm, and exposed to cumulative concentrations of acetylcholine (10-7_1o-5 M).
Bioassay Technique
These experiments were performed according to the procedure described by Rubanyi et al. 21 The segments (3-4 cm) of human placental arteries were cannulated with stainless-steel tubes (0.5 mm o.d.) that allowed each segment to maintain a length similar to that previously measured "in situ" and were placed in an organ bath containing 10 ml oxygenated KHS at 37C. These segments were considered donors and were perfused with KHS by means of a peristaltic pump (Eyela, Tokyo Rikakikai Co.) at a constant rate of 2 ml/min. A stainless-steel tube was also placed in the organ bath, through which KHS was pumped at the same rate. A ring of human placental artery, in which the endothelium had been removed (bioassay ring), was suspended immediately below the organ chamber by means of two steel stirrups passed through its lumen. One stirrup was bound to an isometric force transducer (Panlab, Barcelona, Spain) connected to a polygraph (Houston Instruments, Gistel, Belgium). The assembly of bioassay ring, stirrups, and force transducer could be moved freely below the organ chamber, allowing the preparation to be superfused with the perfusate from either vascular segment or stainless-steel tubing.
A resting tension of 1.5 g (optimal resting tone) was applied to the bioassay ring, which was superfused with KHS passed through the stainless-steel tube (direct superfusion) for a 90-minute equilibration period. During this time, the resting tension was readjusted every 15 minutes until the tone became stable. After this period, the bioassay ring was moved below the outlet from the donor segment. To check the viability of the preparation, 75 mM K' was added to the perfusate at the beginning of the experiments. Afterwards, 10-5 M oua-bain was added by following the protocol described in "Results." 86Rb+ Uptake Studies 86RbW uptake studies were done according to the method of Bukoski et al,22 with minor modifications. Human placental arteries were divided into segments 5 mm in length and then separated into groups of similar weight. Subsequently, each group of vessels was tied to a rigid nylon fiber and immersed for 30 minutes in a vial containing 2 ml oxygenated KHS at 37°C. Afterwards, the tissues were exposed to a K'-free medium for 30 minutes and then put into vials containing 5 ml K'-free Rb+-KHS plus 86RbCl (10`6 M; specific activity, 4.68 mCi/mg) for 1-, 5-, 10-, 15-, or 30-minute incubation periods. Subsequently, the tissues were washed by successive immersion in vials containing 5 ml K'-free Rb+-KHS for five periods of 1 minute. The arteries were then blotted, weighed, digested in 1 ml H202 (30% [wt/vol]) by heating for 5 hours at 100°C, and placed in vials with 2 ml Ready Solv HP (Beckman Instruments, Inc., Fullerton, Calif.); radioactivity was measured with a liquid scintillation counter (model LS-2800, Beckman). Total 'Rb+ uptake was expressed as millimoles per kilogram wet weight. The ouabain-insensitive 86Rb+ uptake was measured by a similar procedure, except that this glycoside (10-'-10-4 M) was added to the bath 30 minutes before the incubation period with 86Rb+. Therefore, ouabain-sensitive 86Rb+ uptake was estimated as the difference between the total and the ouabain-insensitive uptake. In some experiments, vascular segments were previously deendothelialized. 1'Rb+ uptake was calculated from the following formula: 'Rbh in millimoles per kilogram wet weight= (counts per minute in muscle/wet weight in kilograms)x(millimoles Rb+ per liter medium/counts per minute per liter medium).
Removal of Vascular Endothelium
The vascular endothelium was removed by treating the segments with saponin (0.3 mg/ml KHS oxygenated at 37°C) for 5 minutes. 23 Afterwards, the vessels were repeatedly washed with fresh KHS. This procedure causes complete histological endothelial denudation without damaging vascular contractility. Thus, the contractile responses to 75 mM K' were not modified by saponin treatment. The magnitudes of the contractions were 1,318±+134 and 1,178±295 mg before and after saponin treatment, respectively, for placental arteries (n=7) and 1,401+182 and 1,509±314 mg before and after saponin treatment, respectively, for placental veins (n = 8). In some cases, the removal of endothelium was performed by gently rubbing the intimal vessel surface, which provided results similar to those provided by saponin treatment. Because of the lack of adequate pharmacological procedures, histological methods were used at the end of the experiments24 for ascertaining the absence of endothelium. 
Solutions, Drugs, and Statistical Evaluation
Results
Vasomotor Responses
Ouabain (1 x 10-7-3 X 10-5 M) elicited concentrationdependent vasoconstriction in human placental arteries and veins ( Figure 1 ). In arteries, because most of the ouabain contraction occurred between 3 x 10-7 and 10-6 M, additional experiments were performed with intermediate concentrations that are shown in Table 1 . The EC50 values for the glycoside contractile effects were in arteries of 6.4 x 10-7 M (range, from 6.02 x 10-7 to 6.8x 10-7 M) and in veins of 1.02x 10-6 M (range, from 0.58x 10-6 to 1.8x 10-6 M). These responses were not modified by the blockade of a-adrenoceptors with 10-6 M phentolamine (results not shown). When the vascular endothelium was previously denuded by incubating the segments with saponin, maximal contractile responses to the glycoside significantly increased in both kinds of vessels ( Figure 1 , Table 1 ); in this case, EC50 values were of 4.6x10-7 M (range, from 3.8x10-7 to 5.6x10-7 M; p<0.01 with respect to control) and 7.2x 10-7 M (range, from 4.6x 10-7 to 11.2x 10-7 M; p<0.01 with respect to control) in arteries and veins, respectively. The contractions induced in these vessels by the administration of a single concentration of 10-6 M 5 -HT were not modified by endothelium removal. In arteries, contractile responses induced by this amine were 85.2+9.9% and 74.0±9.7% of a previous contraction induced by 75 mM K+, which was of 1,168+ 102 and 1,035+333 mg (n= 11) before and after treatment with saponin, respectively. In veins, the contractions were 96.7±19.3% and 94.6±14.1% of a previous contraction induced by 75 mM K+, which was of 1,760±438 and 1,631±310 mg (n=10) before and after saponin, respectively. In placental arteries and veins precontracted with 10-6 M prostaglandin F2a, the administration of acetylcholine (10-7-10-5 M) did not induce any change in vascular tension (results not shown). Because no clear pharmacological evidence of endothelium-dependent relaxation was available, microscopic testing was performed systematically after the experiments were done. Examples of histological preparations are shown in Figure 2 .
Because similar results were obtained with deendothelialization in chorionic arteries and veins, the follow- ing experiments were performed only in arteries. Pretreatment of these vessels with the cyclooxygenase blocker indomethacin (10 M) did not significantly alter ouabain-evoked contractions, whereas the lipoxygenase inhibitor ETYA (10`M) reduced the response caused by the glycoside (Figure 3 ). This later effect was PlacE 200 -C--Control (23) tndomethacin (7) ETYA (6)°1 50 a 100 0 a~50 not due to the ETYA vehicle, ethanol, because the administration of analogous concentrations of this agent to the bath had no effect on ouabain-induced contractions (results not shown). The NO inactivators phenidone and OxHb as well as NO synthase inhibitor L-NMMA (all of them at 10`M) did not modify the contractile responses produced by ouabain ( Figure 3 ). None of these drugs altered basal tone in isolated segments of human placental arteries (results not shown).
Bioassay Experiments
To confirm the effects of endothelium on the vascular responses induced by ouabain in human placental arteries, bioassay experiments were designed. Ouabain (10 M) was continuously administered to the bioassay ring (without endothelium) for a total time period of 60 minutes by use of two different protocols: In the first protocol, the glycoside passed first through the donor segment (with endothelium) for 30 minutes, causing a contraction that was increased afterwards when the drug was directly added to the bioassay ring for another 30 minutes ( Figure 4A ). In the second protocol, ouabain was first administered directly to the ring for 30 minutes, causing a higher contraction than that observed when it was added through the donor segment. This response was decreased by a 30-minute perfusion of additional glycoside through the donor segment ( Figure 4B ). 6Rb+ Uptake Experiments Human placental arteries exhibited a time-dependent 86Rb accumulation up to 15 minutes, at which time the steady state was reached. Ouabain (10`M) pretreatment for 30 minutes before the incubation with the radioisotope significantly reduced the 86RbW uptake starting at 10 minutes of incubation ( Figure SA) . The difference between total and ouabain-insensitive uptake was considered to be due to sodium pump activity. Ouabain (10`-10`-M) reduced, in a concentrationdependent manner, the 86Rbt uptake observed at 10 minutes of incubation ( Figure 5B ). When the vascular endothelium was removed, a significant reduction of the total 86Rbh uptake was observed; in this case, the glycoside caused maximal decreases of radioactivity Figure 5B ). To discard unspecific effects of saponin on 86Rb+ uptake, nonrelated to deendothelialization, some experiments were performed by removing the endothelium by mechanical rubbing. In this case, the total and ouabain-insensitive 86Rb+ uptake averaged 1.61±0.06 and 1.26±0.07 mmol/kg wet wt, respectively, in segments with and 1.38±0.06 (p<0.05 with respect to control) and 1.31+±0.07 mmol/kg wet wt, respectively, in segments without endothelium (n=6-10).
Discussion Ouabain-induced contractile responses have been reported in different vascular preparations.7,27,28 In hu-man placental vessels, this drug elicited concentrationdependent contractions: this response also corresponds with the effects of digoxin in human placental arteries'2 but differs from the biphasic contraction caused by ouabain in vessels from the human umbilical cord (composed of an early rapid transient component followed by a sustained slow vasoconstriction).13 The sensitivity to ouabain appears to be slightly higher in arteries than in veins. The contractions were entirely due to a direct action of ouabain on smooth muscle cells, because phentolamine did not affect these responses, supporting the lack of adrenergic innervation in this vascular bed. 10, 11, 29 Placental arteries 10 20 30 Time (min) In the present experiments, the removal of vascular endothelium was performed by the incubation of the segments with 0.3 mg/ml saponin for 5 minutes23 or by gently rubbing the intimal surface of the segments. Both procedures did not affect vasocontractile mechanisms, because depolarization with potassium induced similar responses in treated or untreated segments. The endothelial denudation was tested systematically by histological procedures, because acetylcholine did not elicit any vasoactive change in arteries and veins precontracted with prostaglandin F2a, as previously reported.30 '31 The removal of vascular endothelium produced increases in the maximal contractile responses to ouabain in human placental arteries and veins. This finding could be explained by the loss of a tonic release of vasorelaxant factors, such as EDRF/NO or prostacyclin, which has been found in endothelial cells from human umbilical vessels.30,32 However, some facts argue against this possibility. Thus, 5-HT-induced contractions were not enhanced after endothelium removal, as would be expected if basal vasodilatory tone were lost. Therefore, the endothelium appears to modulate ouabain-induced responses but not those evoked by one of the most potent circulating vasoconstrictors of the umbilicoplacental vasculature.29 '33 In addition, the cyclooxygenase inhibitor indomethacin did not increase the contractions produced by the glycoside, indicating the lack of participation of prostaglandins. Furthermore, vasocontractile responses to prostacyclin have been reported in human umbilical arteries. 34 The possible role for endothelium-derived NO as modulator of ouabain contractions was tested by using phenidone and OxHb, which inactivate NO by different mechanisms,25,35 as well as by using the NO synthesis inhibitor L-NMMA.36,37 Neither phenidone, OxHb, nor L-NMMA modified the responses elicited by the glycoside in placental arteries, strongly suggesting that enhancement of ouabain contractions after endothelium removal is not due to the loss of EDRF/NO release. The lipoxygenase blocker ETYA38 did not mimic the effects of endothelium removal on the contractile properties of ouabain in human placental arteries, suggesting that leukotrienes are not involved in endothelial modulation of the glycoside action. The reduced contraction observed after incubation with ETYA could likely be explained by the rather unspecific actions of this drug. 39 To further analyze the interference of endothelium on the effects of ouabain in human placental arteries, bioassay experiments were performed. Distinct responses to ouabain were observed in deendothelialized rings, depending on the manner of drug administration. Direct perfusion of the glycoside into the bioassay ring evoked higher contractions than did its addition through a donor segment with endothelium. Changing the route of drug addition produced different effects: an increased contraction was observed when ouabain was changed to direct addition to the ring, whereas relaxation occurred when the glycoside addition was moved through the donor segment. These effects were lost after the removal of vascular endothelium from donor segments. When all these results are considered, some conclusions can be suggested: 1) The endothelium seems to partially protect the smooth muscle sodium pump from blockade by ouabain. 2) This effect appears to be mediated by a diffusible factor(s). 3) This agent(s)
is not related to prostanoids, leukotrienes, or NO. These facts suggest that the endothelium of human placental vessels is releasing an unknown substance(s) that interacts with Na+,K+-ATPase in the smooth muscle cells, antagonizing the inhibitory actions of ouabain.
The activity of the sodium pump can be tested by means of '6Rb+ uptake (a K+ congener).7'22'40 Differences between the total and ouabain-insensitive '6Rb+ uptake represent the activity of Na+,K+-ATPase,7,22,40 which in human placental arteries was significant after 10 minutes of incubation. When the endothelium was previously removed by using either pharmacological or mechanical procedures, the total '6Rb+ uptake significantly decreased; furthermore, the inhibitory effects of ouabain appeared to be facilitated. These results support the protective effect of endothelium on the vascular smooth muscle sodium pump observed in the reactivity and bioassay experiments and further suggest that endothelial cells can stimulate the Na+,K+-ATPase activity and/or antagonize its blockade by cardiac glycosides.
It is noteworthy that, in cultured vascular smooth muscle from canine aorta, Overbeck et a141 found that the uptake of '6Rb+ is inhibited by plasma from hypertensive animals that contains endogenous digitalis and that this inhibition does not occur when those cells are cocultured with bovine endothelial cells.4' Although the authors did not provide an adequate explanation for that finding, it is consistent with the data from the present work. The contractions induced by ouabain in guinea pig isolated trachea are increased after epithelium removal42; these findings also agree with the present results. Two possibilities have been proposed to explain this later effect: 1) the blockade by the glycoside of a relaxant factor(s) released from epithelial cells and 2) the secretion by the epithelium of a factor(s) that stimulates the activity of the underlying smooth muscle sodium pump. 42 In vascular preparations, the inhibition by ouabain of endothelium-derived relaxations has been reported in canine femoral and coronary arteries.'4'15 This effect can be produced by blocking the release of NO from endothelial cells'16"7 or by the interference with the action of an endothelial factor on smooth muscle cells,16-18 which can be the still-unidentified EDHF,1843-4 a factor that is not NO.45A46 Feletou and Vanhoutte'8 proposed that the mechanism of action of this EDHF could be the stimulation of the Na+,K+-ATPase activity in vascular smooth muscle cells, which allows for establishing an analogy with the endothelial modulation of the smooth muscle sodium pump in human placental vessels. However, there are some facts that challenge this hypothesis: 1) The reported endothelium-dependent hyperpolarization is a transient phenomenon,18,46-48 whereas the endothelial protection of sodium pump observed in these experiments appears to be a tonic effect. 2) Some authors suggest that EDHF actions are not related to sodium pump activity.49 '50 The physiological significance of the present results is unclear, but the findings allow some suggestions. It has been proposed that hypertensive states are related to endogenous compounds that inhibit Na+,K+-ATPase.51-' Recent data suggest that the endogenous sodium pump inhibitor isolated from human plasma can be identified as a substance identical to ouabain.54 In pregnancy-induced hypertension, high levels of endogenous digitalis have been found in the placenta, amnion, and fetal and mother's blood. [55] [56] [57] [58] In addition, Delva et al59 suggested that the origin of the endogenous digitalis could be the placenta. The inhibition of the vascular Na+ pump by these compounds can be blocked by endothelial cells. 41 Our results also suggest that endothelium antagonizes the vascular responses to cardiac glycosides, at least in the placental vasculature. Therefore, the existence of endothelial alterations that have been reported in umbilical vasculature from patients with pregnancy-induced hypertension60 could increase vascular resistance and reduce placental blood flow. However, further investigations are required to establish the possible pathological consequences of this proposal.
